The Filing Desk

Novocure vs UFP Technologies

Novocure NVCR · UFP Technologies UFPT · Health Care Equipment

Novocure reported revenue of $655 million in fiscal 2025, about the same as UFP Technologies' $603 million in fiscal 2025. Novocure's revenue grew 8.3% in its latest year, and UFP Technologies' grew 19.5%. Novocure had an operating margin of -23.5%, against 15.3% at UFP Technologies.

Side by side

NovocureUFP Technologies
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$655M$603M
Revenue growth8.3%19.5%
Revenue growth a year, last 5 years5.8%27.4%
Gross margin74.5%28.3%
Operating margin−23.5%15.3%
Net margin−20.8%11.3%
Free cash flow−$76M—
Free cash flow margin−11.6%—
Return on capital−33.0%14.4%
Net debt to EBITDA—1.0x
Dividends and buybacks$0M$0M
Change in diluted share count3.4%0.2%
Last close$11.83$305.06
P/E at the last close—31.1×
Insider trades, last 12 monthssold $2.9 millionsold $13.6 million
Piotroski F-score4 of 95 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
NovocureUFP Technologies
Operating margin
Percent of revenue
NovocureUFP Technologies
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
NovocureUFP Technologies

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Novocure and UFP Technologies pages.